Arcus Biosciences Inc (RCUS) — Cash Flow Reinvestment Rate
Arcus Biosciences Inc (RCUS) has a Cash Flow Reinvestment Rate of 1.15x as of September 2024, reinvesting $30.00 Million (capex $1.00 Million plus investments $-29.00 Million) from operating cash flow of $26.00 Million. See cash generation quality of Arcus Biosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Arcus Biosciences Inc Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Arcus Biosciences Inc across 2 annual periods. For the full cash flow conversion analysis, see Arcus Biosciences Inc cash flow conversion.
Annual Cash Flow Reinvestment Rate for Arcus Biosciences Inc (2020–2022)
Year-by-year capital reinvestment analysis for Arcus Biosciences Inc. See Arcus Biosciences Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.96x | $419.00 Million | $438.00 Million | $6.00 Million | ▼ -75.5% |
| 2020 | 3.91x | $434.37 Million | $111.17 Million | $3.06 Million | — |